文献速递母胎医学

国际产前诊断学会2022年辩论:提供胎儿治疗的机构应实施正式认证与持续质量保证/审查并公开报告结局

International Society for Prenatal Diagnosis 2022 DEBATE: There should be formal accreditation and ongoing quality assurance/review for units offering fetal therapy that includes public reporting of outcomes.
PubMed 文献 · Prenat Diagn · 2022-12-21

本文为国际产前诊断学会2022年辩论稿,讨论胎儿治疗机构是否应实施正式认证、持续质量保证/审查并公开报告结局。文中指出当前已发表证据显示较新胎儿治疗中心的干预结局与更有经验中心相似,且结局随时间改善。作者认为正式认证、质量控制与结局报告难以实施且昂贵,但国际学会已承诺质量改进,强烈推荐胎儿治疗项目参与自愿性结局追踪。

要点

  • 已发表证据显示较新胎儿治疗中心的干预结局与更有经验中心相似,且结局随时间改善。
  • 正式协作网络如NAFTnet等允许对中心结局进行匿名基准比较,而不公开羞辱表现不佳的中心。
  • 国际学会已承诺质量改进,强烈推荐胎儿治疗项目参与自愿性结局追踪。

核心结论

  • 尽管正式认证、质量控制与结局报告存在困难且昂贵,国际学会已承诺质量改进,强烈推荐胎儿治疗项目参与自愿性结局追踪。

研究设计与样本

  • 本文为国际产前诊断学会2022年辩论稿,讨论胎儿治疗机构认证与质量保证议题。

主要发现

  • 当前已发表证据显示较新胎儿治疗中心的干预结局与更有经验中心相似,且干预结局随时间改善。
  • 正式协作网络如NAFTnet等允许对中心结局进行匿名基准比较,而不公开羞辱表现不佳的中心。
  • 大型登记系统可追踪罕见并发症,并可能随时间改善患者结局。
  • 部分病种已有核心结局集可用作结局报告基础,但并非所有病种均有,导致中心间沟通困难。
  • 正式认证、质量控制与结局报告难以实施且昂贵,可能因将较小中心挤出市场而减少医疗可及性。

关键数值与推荐

  • 国际学会已承诺质量改进,强烈推荐胎儿治疗项目参与自愿性结局追踪。

临床怎么用

  • 原文未据此给出具体临床推荐。

局限性

  • 许多干预缺乏随机对照试验的1级证据。
  • 核心结局集仅对部分病种可用,并非所有病种均有。
  • 正式认证、质量控制与结局报告难以实施且昂贵,可能减少医疗可及性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The field of fetal therapy has so far escaped from formal accreditation and quality control. Despite that, current published evidence shows that outcomes of interventions in younger fetal therapy centers are similar to what is achieved in more experienced centers and outcomes of interventions have improved over time. The question however remains what is not being published and what should be the standard of care, given the lack of level 1 evidence from randomized controlled trials for many interventions. Formal collaborative networks such as NAFTnet and others allow for anonymized benchmarking of center outcomes, without publicly shaming (and financially punishing) underperforming centers. Large registries also allow for tracking of rare complications and may result in improved patient outcomes over time. Core outcome sets, which could serve as a basis for outcome reporting, are available for some conditions, but certainly not for all, resulting in communication difficulties between centers. Formal accreditation, quality control, and outcome reporting are hard to implement, expensive, and may result in decreasing access to care by pushing smaller centers out of the market. Despite the existing difficulties, international societies have committed to quality improvement, and fetal therapy programs are strongly recommended to participate in voluntary outcome tracking.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Moldenhauer JS, Johnson A, Van Mieghem T, et al. International Society for Prenatal Diagnosis 2022 DEBATE: There should be formal accreditation and ongoing quality assurance/review for units offering fetal therapy that includes public reporting of outcomes. Prenat Diagn. 2022. PMID: 36522853. doi:10.1002/pd.6286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。